Literature DB >> 8353708

Reliability of histological diagnosis including grading in gliomas biopsied by image-guided stereotactic technique.

T Revesz1, F Scaravilli, L Coutinho, H Cockburn, P Sacares, D G Thomas.   

Abstract

We report clinical and pathological data of 419 image-guided stereotactic biopsies. In the present series the diagnostic yield, estimated by comparing the original histological diagnoses with follow-up data, was found to be approximately 94% in gliomas. As it has been suggested that malignancy of astrocytic gliomas may be considerably underestimated in the small tissue samples obtained by stereotactic biopsy, we have reviewed 160 adult, diffuse supratentorial astrocytic tumours, correlating the original Kernohan tumour grades with survival. In this grading system, although there was generally a good correlation between histological grade and survival probability (P < 0.0001), no distinction could be made between the grade 3 (anaplastic astrocytoma) and grade 4 (glioblastoma) groups. Tumour grades obtained by applying the criteria of the more recent Daumas-Duport grading system were also determined and correlated with survival. These latter tumour grades not only correlated well with survival (P < 0.0001), but also enabled us to identify a group of patients with intermediate grade malignancy (grade 3, anaplastic astrocytoma), surviving longer than those with grade 4 tumours. Image-guided stereotactic biopsy is a useful means of providing tissue samples for histological diagnosis of brain neoplasms, including gliomas. Histological grading of adult, diffuse supratentorial astrocytic gliomas diagnosed by this technique is possible and should be carried out using an appropriate grading system.

Entities:  

Mesh:

Year:  1993        PMID: 8353708     DOI: 10.1093/brain/116.4.781

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  9 in total

Review 1.  Management of newly diagnosed glioblastoma: guidelines development, value and application.

Authors:  Jeffrey J Olson; Camilo E Fadul; Daniel J Brat; Srinivasan Mukundan; Timothy C Ryken
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

2.  Diagnosis of malignant glioma: role of neuropathology.

Authors:  Daniel J Brat; Richard A Prayson; Timothy C Ryken; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2008-08-20       Impact factor: 4.130

Review 3.  Complications and expected outcome of glioma surgery.

Authors:  K P Vives; J M Piepmeier
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

4.  Trends in classification, referral and treatment and the effect on outcome of patients with glioma: a 20 year cohort.

Authors:  S C Erridge; M G Hart; G R Kerr; C Smith; S McNamara; R Grant; A Gregor; I R Whittle
Journal:  J Neurooncol       Date:  2011-03-08       Impact factor: 4.130

5.  Sub-classification of low-grade cerebellar astrocytoma: is it clinically meaningful?

Authors:  Tine Bernhardtsen; Henning Laursen; Marie Bojsen-Møller; Flemming Gjerris
Journal:  Childs Nerv Syst       Date:  2003-09-30       Impact factor: 1.475

Review 6.  Clinical outcomes as a function of the number of samples taken during stereotactic needle biopsies: a meta-analysis.

Authors:  Sanjay Dhawan; Andrew S Venteicher; William E Butler; Bob S Carter; Clark C Chen
Journal:  J Neurooncol       Date:  2021-07-12       Impact factor: 4.130

7.  Allele loss on chromosomes 10 and 17p and epidermal growth factor receptor gene amplification in human malignant astrocytoma related to prognosis.

Authors:  S Leenstra; E K Bijlsma; D Troost; J Oosting; A Westerveld; D A Bosch; T J Hulsebos
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

8.  Use of Preoperative Apparent Diffusion Coefficients to Predict Brain Tumor Grade.

Authors:  Aneela Darbar; Muhammad Waqas; Syed Faaiz Enam; Shaikh D Mahmood
Journal:  Cureus       Date:  2018-03-07

Review 9.  The role of neuropathology in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.

Authors:  Daniel P Cahill; Andrew E Sloan; Brian V Nahed; Kenneth D Aldape; David N Louis; Timothy C Ryken; Steven N Kalkanis; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2015-11-03       Impact factor: 4.130

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.